HopeStage
Back to all studies
CompletedNCT02977299

Switching or Adding Treatment for Depression That Has Not Responded to Antidepressants

About this titleRead the official source — NCT02977299
Medication studyAges 18–80United States + Canada
The study in practice

Understand this study

Who was this study for?

Listed age limits: 18 years to 80 years.

Listed locations
Birmingham and 12 more locationsSee all locations and recruitment
Study phase
Phase 4Usually happens after approval, to monitor real-world use, safety, and longer-term outcomes.

Get this study by email

HopeStage may email me about this study.
Loading the security check...
Study clarity

Study information

Study start dateStarted: July 13, 2017
Recruitment status
Completed
Enrollment listed in the registry
278
Sponsor
Massachusetts General Hospital
Sponsor type
Hospital / academic medical center
Study type
Drug
Intervention type
Device, Drug
Study phase
Phase 4Usually happens after approval, to monitor real-world use, safety, and longer-term outcomes.
Locations
United States, Canada
Age range
From 18 Years to 80 Years
Official registry ID
NCT02977299
Official title
Show the full official title

Augmentation Versus Switch: Comparative Effectiveness Research Trial for Antidepressant Incomplete and Non-responders With Treatment Resistant Depression (ASCERTAIN-TRD)

Looking for a study you can join?

Explore recruiting studies

Recruitment & locations

Completed

Birmingham, United States · Los Angeles, United States · Stanford, United States

10 more locations
  • Tampa, United States
  • Chicago, United States
  • New York, United States
  • Cincinnati, United States
  • Philadelphia, United States
  • Charleston, United States
  • Dallas, United States
  • Houston, United States
  • Vancouver, Canada
  • Winnipeg, Canada

Interested in joining this study?

HopeStage may email me about this study.
Loading the security check...
FAQ

Questions about this study

Who is behind this study?

The study sponsor is Massachusetts General Hospital, a hospital or academic medical center.

Did this study involve medication?

Yes. The study involved medication, including Aripiprazole and Venlafaxine XR.

Who was this study for?

Listed age limits: 18 years to 80 years.

Want to explore more studies?

Explore studies